These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12585953)

  • 1. Restoring balance to industry-academia relationships in an era of institutional financial conflicts of interest: promoting research while maintaining trust.
    Johns MM; Barnes M; Florencio PS
    JAMA; 2003 Feb; 289(6):741-6. PubMed ID: 12585953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is conflict of interest becoming a challenge for institution-based institutional review boards?
    Freedman RS; McKinney R
    Clin Cancer Res; 2013 Aug; 19(15):4034-9. PubMed ID: 23741065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Handling conflicts of interest between industry and academia.
    Egilman DS; Ehrle LH
    JAMA; 2003 Jun; 289(24):3240; author reply 3240-1. PubMed ID: 12824203
    [No Abstract]   [Full Text] [Related]  

  • 4. The connection between academia and industry.
    Singh A; Singh S
    Mens Sana Monogr; 2005 Mar; 3(1):5-35. PubMed ID: 22679346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protecting subjects, preserving trust, promoting progress II: principles and recommendations for oversight of an institution's financial interests in human subjects research.
    AAMC Task Force on Financial Conflicts of Interest in Clinical Research
    Acad Med; 2003 Feb; 78(2):237-45. PubMed ID: 12584107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Look beyond financial conflicts of interest in evaluating industry-academia collaborations in burden-of-illness and outcomes research studies in dermatology.
    Prendergast MM; Abramovits W; Boguniewicz M; Lebwohl M; Tokar M; Tong KB
    J Invest Dermatol; 2004 Sep; 123(3):452-4. PubMed ID: 15304081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Financial conflicts of interest in human subjects research: the problem of institutional conflicts.
    Barnes M; Florencio PS
    J Law Med Ethics; 2002; 30(3):390-402. PubMed ID: 12497699
    [No Abstract]   [Full Text] [Related]  

  • 9. Institutional Conflicts of Interest in Academic Research.
    Resnik DB
    Sci Eng Ethics; 2019 Dec; 25(6):1661-1669. PubMed ID: 26446768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scope and impact of financial conflicts of interest in biomedical research: a systematic review.
    Bekelman JE; Li Y; Gross CP
    JAMA; 2003 Jan 22-29; 289(4):454-65. PubMed ID: 12533125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disclosure, transparency, and accountability: a qualitative survey of public sector pharmaceutical committee conflict of interest policies in the World Health Organization South-East Asia Region.
    Grundy Q; Parker L; Wong A; Fusire T; Dimancesco D; Tisocki K; Walkowiak H; Vian T; Kohler J
    Global Health; 2022 Mar; 18(1):33. PubMed ID: 35303902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conflict of interest and the university.
    Resnik DB; Shamoo AE
    Account Res; 2002; 9(1):45-64. PubMed ID: 12705246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responses of medical schools to institutional conflicts of interest.
    Ehringhaus SH; Weissman JS; Sears JL; Goold SD; Feibelmann S; Campbell EG
    JAMA; 2008 Feb; 299(6):665-71. PubMed ID: 18270355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Financial conflicts of interest in biomedical research: the need to improve the system.
    Wang AT; Montori VM; Murad MH
    Drug News Perspect; 2010 Nov; 23(9):607-12. PubMed ID: 21152455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Industry, academia, investigator: managing the relationships.
    Korn D
    Acad Med; 2002 Nov; 77(11):1089-95. PubMed ID: 12431917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complexities of individual financial conflicts of interest.
    Rubin EH
    Neuropsychopharmacology; 2005 Jan; 30(1):1-6. PubMed ID: 15470374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protecting subjects, preserving trust, promoting progress I: policy and guidelines for the oversight of individual financial interests in human subjects research.
    AAMC Task Force on Financial Conflicts of Interest in Clinical Research
    Acad Med; 2003 Feb; 78(2):225-36. PubMed ID: 12584106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Policies on faculty conflicts of interest at US universities.
    Cho MK; Shohara R; Schissel A; Rennie D
    JAMA; 2000 Nov; 284(17):2203-8. PubMed ID: 11056591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Content Analysis of Patient Advocacy Organization Policies Addressing Institutional Conflicts of Interest.
    Brems JH; McCoy MS
    AJOB Empir Bioeth; 2019; 10(4):215-221. PubMed ID: 31593523
    [No Abstract]   [Full Text] [Related]  

  • 20. Fostering innovation without compromising integrity.
    Pizzo PA
    Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S10-1; discussion 16-22. PubMed ID: 17469467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.